Hyperthermia Combined With Neoadjuvant Radiochemotherapy for LARC
Clinical trial NCT05070832 · UNKNOWN
Trial details
- NCT number
- NCT05070832
- Sponsor
- Peking University Third Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2023-12-31
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.